Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Huifan Yu"'
Autor:
Jie Li, Junyu He, Haibo He, Xiao Wang, Shuran Zhang, Yumin He, Jihong Zhang, Chengfu Yuan, HongWu Wang, Daoxiang Xu, Chaowang Pan, Huifan Yu, Kun Zou
Publikováno v:
Current Research in Food Science, Vol 8, Iss , Pp 100677- (2024)
Our prophase studies have manifested that the sweet triterpenoid glycoside from the leaves of Cyclocarya paliurus (CPST) effectively improved the disorders of glucolipid metabolism in vitro and in patients. The current purpose was to further detect i
Externí odkaz:
https://doaj.org/article/a5cf3ec1012e4b8db94fec98b47967c3
Autor:
Linsheng Huang, Junxiang Han, Huifan Yu, Jialing Liu, Lili Gui, Zhengkun Wu, Xinxu Zhao, Shiqi Su, Gaohang Fu, Fei Li
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundPancreatic cancer is a fatal disease with a very poor prognosis due to its characteristic insidious symptoms, early metastasis, and chemoresistance. Circular RNAs (circRNAs) are involved in the development of pancreatic cancer.AimHence, the
Externí odkaz:
https://doaj.org/article/08033e00329749c59dd12f3a07377d63
Autor:
Simei Lin, Jia Meng, Fei Li, Huifan Yu, Dongmei Lin, Shuqian Lin, Min Li, Hong Zhou, Baoxue Yang
Publikováno v:
Food & Function. 13:12619-12631
In this study,Ganoderma lucidumpolysaccharide decreased blood uric acid in potassium oxonate induced hyperuricemic mice and exerted renal protective effect.
Autor:
Guohua Zheng, Shengfu Yi, Liang Chen, Cong Zhang, Yan Meng, Huifan Yu, Junjie Hu, Shan Li, Guihong Wang, Zhenpeng Qiu
Publikováno v:
AAPS PharmSciTech. 22
Urolithin A (Uro-A), a metabolite of ellagitannins in mammals’ intestinal tract, displays broad biological properties in preclinical models, including anti-oxidant, anti-inflammatory, and anti-tumor effects. However, the clinical application of Uro
Publikováno v:
Pharmaceutical Care and Research. 17:202-205
Autor:
Lei Sheng, Huifan Yu, Guohua Zheng, Yong Wu, Liang Chen, Shan Li, Junjie Hu, Zhenpeng Qiu, Ming Yuan, Cong Zhang, Yan Meng
Publikováno v:
Toxicology and Applied Pharmacology. 392:114918
Orlistat (Xenical™), a US Food and Drug Administration (FDA)-approved anti-obesity drug, shows efficacy against multiple tumor types, including hepatocellular carcinoma (HCC), due to its ability to inhibit fatty acid synthase (FASN) activity. Howev
Publikováno v:
International journal of biological macromolecules. 111
In this study, chemical properties of polysaccharides from rhizomes of Panax japonicus C. A. Mey (PSPJ) were investigated and the antitumor immunostimulatory activity of PSPJ was assessed in mice bearing H22 hepatoma cells. Chemical properties of PSP